122 related articles for article (PubMed ID: 7515683)
21. Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro.
Qiao ZS; Guo ZY; Feng YM
Biochemistry; 2001 Mar; 40(9):2662-8. PubMed ID: 11258877
[TBL] [Abstract][Full Text] [Related]
22. Chaperone-like effect during in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner.
Samuelsson E; Uhlen M
Ann N Y Acad Sci; 1996 May; 782():486-94. PubMed ID: 8659919
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.
Sato A; Koyama S; Yamada H; Suzuki S; Tamura K; Kobayashi M; Niwa M; Yasuda T; Kyogoku Y; Kobayashi Y
J Pept Res; 2000 Oct; 56(4):218-30. PubMed ID: 11083061
[TBL] [Abstract][Full Text] [Related]
24. Flexibility exists in the region of [A6-A11, A7-B7] disulfide bonds during insulin precursor folding.
Liu Y; Wang ZH; Tang JG
J Biochem; 2004 Jan; 135(1):1-6. PubMed ID: 14999003
[TBL] [Abstract][Full Text] [Related]
25. 1.42A crystal structure of mini-IGF-1(2): an analysis of the disulfide isomerization property and receptor binding property of IGF-1 based on the three-dimensional structure.
Yun CH; Tang YH; Feng YM; An XM; Chang WR; Liang DC
Biochem Biophys Res Commun; 2005 Jan; 326(1):52-9. PubMed ID: 15567151
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115
[TBL] [Abstract][Full Text] [Related]
27. Peptide models of four possible insulin folding intermediates with two disulfides.
Jia XY; Guo ZY; Wang Y; Xu Y; Duan SS; Feng YM
Protein Sci; 2003 Nov; 12(11):2412-9. PubMed ID: 14573855
[TBL] [Abstract][Full Text] [Related]
28. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
[TBL] [Abstract][Full Text] [Related]
29. In vitro refolding/unfolding pathways of amphioxus insulin-like peptide: implications for folding behavior of insulin family proteins.
Chen Y; Jin R; Dong HY; Feng YM
J Biol Chem; 2004 Dec; 279(53):55224-33. PubMed ID: 15501824
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors (IGFs) and IGF binding protein-3 display disulfide isomerase activity.
Koedam JA; van den Brande JL
Biochem Biophys Res Commun; 1994 Feb; 198(3):1225-31. PubMed ID: 7509599
[TBL] [Abstract][Full Text] [Related]
31. Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.
Sohma Y; Hua QX; Liu M; Phillips NB; Hu SQ; Whittaker J; Whittaker LJ; Ng A; Roberts CT; Arvan P; Kent SB; Weiss MA
J Biol Chem; 2010 Feb; 285(7):5040-55. PubMed ID: 19959476
[TBL] [Abstract][Full Text] [Related]
32. Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.
Ständker L; Braulke T; Mark S; Mostafavi H; Meyer M; Höning S; Giménez-Gallego G; Forssmann WG
Biochemistry; 2000 May; 39(17):5082-8. PubMed ID: 10819974
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-I (IGF-I) concentration in 150-kilodalton complexes containing human IGF-binding protein-3 (hIGFBP-3) after intravenous injection of adult rats with hIGFBP-3.
Lee CY; Wu HB; Suh DS; Rechler MM
Endocrinology; 1997 Apr; 138(4):1649-57. PubMed ID: 9075727
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
35. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
36. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
Jansson M; Uhlen M; Nilsson B
Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
[TBL] [Abstract][Full Text] [Related]
37. Native and non-native structure in a protein-folding intermediate: spectroscopic studies of partially reduced IGF-I and an engineered alanine model.
Hua QX; Narhi L; Jia W; Arakawa T; Rosenfeld R; Hawkins N; Miller JA; Weiss MA
J Mol Biol; 1996 Jun; 259(2):297-313. PubMed ID: 8656430
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
[TBL] [Abstract][Full Text] [Related]
39. Affinity-assisted in vivo folding of a secreted human peptide hormone in Escherichia coli.
Samuelsson E; Jonasson P; Viklund F; Nilsson B; Uhlén M
Nat Biotechnol; 1996 Jun; 14(6):751-5. PubMed ID: 9630984
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum.
Baxter RC; Suikkari AM; Martin JL
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):847-52. PubMed ID: 7691057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
